Clearance Summary
Alere i Influenza A & B, Alere i Strep A, Alere i RSV, Alere i Influenza A & B 2 received FDA 510(k) clearance under submission number K173932, sponsored by Alere Scarborough, Inc.. The device was reviewed via the Special premarket notification pathway and assigned to the Microbiology review panel. The statutory decision date of record is 2018-01-26.
- Submission: K173932
- Applicant / Sponsor: Alere Scarborough, Inc.
- Clearance pathway: Special
- Review panel: Microbiology
- Device class: Class II
- Regulation citation: 21 CFR 866.3980
- Decision date: 2018-01-26
Classification & Regulation
This clearance is catalogued under FDA product code OCC and 21 CFR 866.3980, within the Microbiology review panel as a Class II device.